课题基金 / 基金详情

Delineating molecular mechanisms of DNA repair through protein engineering

Delineating molecular mechanisms of DNA repair through protein engineering
通过蛋白质工程描绘 DNA 修复的分子机制
批准号:
RGPIN-2019-05721
负责人:
Zhang, Wei
金额:
$2.99万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2021
资助国家:
加拿大
项目状态:
已结题
起止时间:
2021-01-01 至 2022-12-31

项目摘要

项目成果

Zhang, Wei的其他基金

相似基金

相关文献

中文摘要
翻译
DNA修复是一个基本的生物学过程,也是所有生物体基因组稳定性和完整性的重要保障。在蛋白质水平,DNA修复组分主要受两种类型的翻译后修饰的调节:泛素化和磷酸化。它们共同构成了检测DNA损伤的信号事件,将蛋白质募集到受损的染色质中,并激活修复机制以恢复受损的DNA。然而,它仍然是知之甚少的个别蛋白质-蛋白质相互作用(PPI)的泛素化和磷酸化elevently在整合的信号网络的背景下的生物功能。因此,迫切需要合成的PPI改性剂,可以很容易地适应不同的系统进行功能分析。为了解决这个问题,我设计了一种蛋白质工程策略来开发新的基于蛋白质的PPI抑制剂和激活剂,这使得能够发现泛素化系统中不同蛋白质家族的新生化机制和新生物学功能。展望未来,我的研究计划的长期目标是建立一个生物分子工程平台,用于开发有效和特异性的PPI调节剂,以前所未有的精确度探测和重新连接DNA修复信号,以了解潜在的分子机制。在接下来的五年里,我的短期目标是了解中央DNA修复E3泛素连接酶BRCA 1-BARD 1如何触发细胞效应以保持基因组的完整性,以及多个BRCA 1蛋白复合物如何去卷积磷酸化信号以协调DNA双链断裂(DSB)的修复,DSB是最具细胞毒性的DNA损伤类型。为了实现这些目标,我们将设计各种蛋白质支架,用于合成BRCA 1-BARD 1酶活性和复合物组装的抑制剂和激活剂。这些合成分子将使我们对BRCA 1-BARD 1在DNA损伤信号转导和DSB修复途径选择中的作用的理解取得重大进展。此外,新的泛素化底物和BRCA 1-BARD 1的新磷酸依赖性相互作用将被确定,使我们和DNA修复研究界能够剖析人类细胞中DSB损伤信号传导的基本分子结构。因此,这项工作将对我们在DNA修复和其他信号通路中调节其他Ub和磷酸依赖性PPI的长期目标产生重要影响。至关重要的是,高素质人员(HQP)将接受蛋白质工程和合成生物学方面的培训,培养急需的技能和专业知识,以利用最近的基因组学革命并解决关键生物过程中的基本问题。
英文摘要
DNA repair is a fundamental biological process and an essential safeguard of genome stability and integrity for all living organisms. At the protein level, DNA repair components are mainly regulated by two types of post-translational modifications: ubiquitination and phosphorylation. Together, they constitute signaling events that detect DNA damage, recruit proteins to the damaged chromatin, and activate the repair machinery to restore damaged DNA. However, it is still poorly understood how individual protein-protein interaction (PPI) in ubiquitination and phosphorylation elicits biological functions in the context of integrated signaling networks. Thus, there is an urgent need of synthetic PPI modifiers that can be easily adapted into different systems for functional analysis. To solve this problem, I have devised a protein engineering strategy to develop novel protein-based PPI inhibitors and activators, which enabled discovery of new biochemical mechanisms and new biological functions for diverse protein families in the ubiquitination system. Going forward, the long-term goal of my research program is to establish a biomolecular engineering platform for the development of potent and specific PPI modulators to probe and rewire DNA repair signaling with unprecedented precision for underlying molecular mechanisms. Over the next five years, my short-term goal is to understand how the central DNA repair E3 ubiquitin ligase BRCA1-BARD1 triggers cellular effects to preserve genome integrity and how multiple BRCA1 protein complexes deconvolute phosphorylation signals to orchestrate repair of DNA double-strand breaks (DSBs), the most cytotoxic type of DNA damage. To achieve these objectives, we will engineer a variety of protein scaffolds for synthetic inhibitors and activators of BRCA1-BARD1 enzymatic activity and complex assembly. Theses synthetic molecules will empower significant advances of our understanding for BRCA1-BARD1's role in DNA damage signal transduction and DSB repair pathway choice. Moreover, new ubiquitination substrates and new phospho-dependent interactions of BRCA1-BARD1 will be identified, allowing us and the DNA repair research community to dissect the fundamental molecular architecture of DSB damage signaling in human cells. This work will therefore have critical implications for our long-term goal of modulating other Ub- and phospho-dependent PPIs in DNA repair and other signaling pathways. Crucially, highly qualified personnel (HQP) will be trained in protein engineering and synthetic biology, developing skills and expertise that are urgently needed to capitalize on the recent genomics revolution and address fundamental questions in critical biological processes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Delineating molecular mechanisms of DNA repair through protein engineering
  • 批准号:
    RGPIN-2019-05721
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2022
  • 负责人:
    Zhang, Wei
  • 依托单位:
Delineating molecular mechanisms of DNA repair through protein engineering
  • 批准号:
    RGPIN-2019-05721
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2020
  • 负责人:
    Zhang, Wei
  • 依托单位:
Delineating molecular mechanisms of DNA repair through protein engineering
  • 批准号:
    DGECR-2019-00471
  • 项目类别:
    Discovery Launch Supplement
  • 资助金额:
    $0.91万
  • 财政年份:
    2019
  • 负责人:
    Zhang, Wei
  • 依托单位:
Delineating molecular mechanisms of DNA repair through protein engineering
  • 批准号:
    RGPIN-2019-05721
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2019
  • 负责人:
    Zhang, Wei
  • 依托单位:
国内基金
海外基金
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
  • 批准号:
    82371616
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姚晨成
  • 依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
  • 批准号:
    82370981
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    陈敏洁
  • 依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
  • 批准号:
    82372073
  • 项目类别:
    面上项目
  • 资助金额:
    48.00万元
  • 批准年份:
    2023
  • 负责人:
    张淼
  • 依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
  • 批准号:
    82371652
  • 项目类别:
    面上项目
  • 资助金额:
    45.00万元
  • 批准年份:
    2023
  • 负责人:
    刘开江
  • 依托单位: